The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Megace 160 mg tablets

PharmaSwiss Ceska republika s.r.o.PA1696/002/001

Main Information

Trade NameMegace 160 mg tablets
Active SubstancesMegestrol acetate
Dosage FormTablet
Licence HolderPharmaSwiss Ceska republika s.r.o.
Licence NumberPA1696/002/001

Group Information

ATC CodeL02AB Progestogens
L02AB01 megestrol


License statusAuthorised
Licence Issued06/02/1989
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back